Startup Gains Funding for New Hypothermia Therapy Tech

Hypothermia therapy (also known as hypothermia treatment, therapeutic hypothermia treatment, or brain and/or body cooling) is key to treating hypoxic-ischemic encephalopathy (HIE) in neonates, and so the development or funding of new technologies for making hypothermia therapy more efficient is always good news. We’d like to highlight a newcomer to the field Qool Therapeutics.

Qool Therapeutics has just completed its seed financing round and is launching its Series A1 financing round for a new, non-invasive, field-deployable therapeutic hypothermia device. The device delivers aerosolized frozen saline particles to the lungs. There, it has direct access to the heart and brain, allowing for more efficient cooling, first of the heart and brain, and then of the rest of the body. According to Qool Therapeutics, the device has undergone feasibility studies that demonstrate that it can cool faster than current competitor devices with no negative effects. 

Cooling devices such as Qool Therapeutics’ new product are currently slated for use in adults and athletes but could be adapted to the treatment of infants with hypoxic-ischemic encephalopathy (HIE), stroke, traumatic brain injury, meningitis, heat stroke, and sepsis.

Because it is still in A1 series funding, it is unlikely that we will see this new device on the market soon (it must still go through production, stringent testing and clinical trials, and other processes), but this news is still promising.

What Does Efficient Hypothermia Therapy Mean for Hypoxic Ischemic Encephalopathy (HIE)?

Therapeutic hypothermia is the only line of defense in remediating the effects of hypoxic-ischemic insults. Developing fast-acting, precise hypothermia therapy devices is one part of having good outcomes for neonates with injuries from birth asphyxia, neonatal encephalopathy, and fetal oxygen deprivation. A fast-acting hypothermia therapy device such as the one Qool Therapeutics is proposing would be a boon to HIE treatment (if and/or when the device is adapted for the specific needs of neonates). As it stands, HIE can be a severely disabling brain injury, resulting in cerebral palsy, cognitive impairments, developmental delays and intellectual disabilities, and motor and speech deficits. The faster hypothermia therapy is administered, the more effective it is at healing or reducing the damage that a hypoxic-ischemic event can inflict on the developing brain. Fast-acting hypothermia therapy devices are one way to reduce the amount of time it takes to treat an infant with HIE.

Such therapeutic devices are not, however, a panacea for healing birth injuries. The best way to ensure good outcomes for infants is to provide safe medical care that avoids HIE entirely. In the case of preventable birth injuries, this means physicians must follow the standard of care when treating their patients. A more effective treatment device for an injury is no substitute for safe medical care that avoids injuries in the first place.


Legal Help for Hypothermia Therapy

Because HIE often results in serious, lifelong injuries, the experienced attorneys at Reiter & Walsh ABC Law Centers are here to assist parents whose children have suffered HIE due to medical errors. It is inexcusable for a medical professional to cause injury as a result of deviation from standards of care in treating expectant mothers and fragile newborns. Our birth trauma attorneys can review your medical records to determine whether you have a medical malpractice case and inform you of your legal options. Reach out to us for a free case evaluation.

Free Case Review | Available 24/7 | No Fee Until We Win

Phone (toll-free): 888-419-2229
Press the Live Chat button on your browser
Complete Our Online Contact Form

Related Resources:

Share This Post

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply